A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines

Tomasz Korzeniowski; Jerzy Strużyna; Anna M. Chrapusta; Andrzej Krajewski; Marek Kucharzewski; Krzysztof Piorun; Jakub Nowakowski; Agnieszka Surowiecka; Magdalena Kozicka; Kamil Torres

doi:10.12659/MSM.935632

22 January 2022: Clinical Research

A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid) in Burns Following the 2020 Updated European Consensus Guidelines

Tomasz Korzeniowski ^12ABCDEFG* , Jerzy Strużyna ^13ACDEFG , Anna M. Chrapusta ^4ABCDE , Andrzej Krajewski ^5ABDE , Marek Kucharzewski ^6ABDEF , Krzysztof Piorun ^5ABCE , Jakub Nowakowski ^7BCDF , Agnieszka Surowiecka ^1ACDE , Magdalena Kozicka ^12ABDF , Kamil Torres ^12BDEG

DOI: 10.12659/MSM.935632

Med Sci Monit 2022; 28:e935632

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

View HTML version

Table 2 Consensus statements and agreement on pain management for enzymatic debridement.

No	Statement	Agreement	Likert scale	Consensus
9	Adequate pain management is an inherent requirement of enzymatic debridement-based treatment	100%	5/5 strongly agree	Yes

Back to the Article

A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid) in Burns Following the 2020 Updated European Consensus Guidelines

Your Privacy